Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 6:55 AM ET

Health Care Technology

Company Overview of SurgiQuest, Inc.

Company Overview

SurgiQuest, Inc. develops, manufactures, and markets technology solutions for minimally invasive surgery. It offers AirSeal, a dynamic pressure system technology used for general laparoscopic surgery; single port surgery; colorectal, gynecologic, urologic, and bariatric laparoscopy; endoluminal surgery; and transluminal surgery. The company also provides AnchorPort that provides clinical advantage for surgeons in the areas of colorectal, gynecologic, urologic, and bariatric laparoscopy; general laparoscopic surgery; single incision laparoscopy; and transluminal surgery. It serves clients in Australia, Austria, Chile, Japan, Italy, Jordan, Korea, Kuwait, the Netherlands, Qatar, Saudi Arabia, ...

333 Quarry Road

Milford, CT 06460

United States

Founded in 2005





Key Executives for SurgiQuest, Inc.

Founder, Chief Executive Officer and Director
Senior Director of Operations
Chief Medical Director
Vice President of Marketing & Sales
Director of Marketing
Compensation as of Fiscal Year 2015.

SurgiQuest, Inc. Key Developments

SurgiQuest, Inc. Airseal System Receive FDA 510(K) Clearance for Transanal Endoscopic Surgery

SurgiQuest, Inc. announced that its AirSeal System received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES). To date, the growth of transanal endoscopic surgery has been limited due to the technological constraints of conventional insufflation technology which is unable to provide a consistent, smoke-free working space. Because the AirSeal System ensures stable insufflation of the rectum and provides continuous smoke evacuation, surgeons can now perform TES with increased confidence, thus enabling faster adoption and proliferation within the global colorectal community. The category of transanal endoscopic surgery includes both transanal minimally invasive surgery (TAMIS) and transanal total mesorectal excision (TaTME), a surgical technique that has been shown to significantly improve patient outcomes in colorectal cancer procedures.

SurgiQuest, Inc. Names Jaime Landman, M.D. as Chief Medical Director

SurgiQuest, Inc. announced the appointment of Jaime Landman, M.D. as Chief Medical Director of the company. Dr. Landman is currently a Professor of Urology and Radiology and the Chairman of the Department of Urology at the University of California, Irvine School of Medicine.

SurgiQuest, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:30 AM

SurgiQuest, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Thomas Dugan, President and Chief Commercialization Officer.

Similar Private Companies By Industry

Company Name Region
Alpha Systems United States
ScriptRx, Inc. United States
DeJarnette Research Systems, Inc. United States
VestaCare, Inc. United States
Omega Technology Solutions, LLC United States

Recent Private Companies Transactions

Private Placement
March 10, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SurgiQuest, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at